Febe van Maldegem

12PUBLICATIONS
91CO-AUTHORS
Tumour immunologyCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsComputational imaging
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 10, 2026
PLA2G2D in tumour-draining lymph nodes regulates anti-tumour immunity.

|Jul 06, 2026
Statescope: an integrative deconvolution framework for discovering cell states in tumors.

|Jun 22, 2026
Rescue by radiotherapy and anti-CTLA4/PD-1 after failure of anti-PD-1 therapy in patients with metastatic NSCLC: the phase II RECLAIM trial.

|Nov 28, 2025
Immune-modulating effects on tumor-draining lymph nodes of neoadjuvant chemoradiotherapy combined with dual immunotherapy in patients with T3-4N0-2 NSCLC.

Ezgi B Ulas, Sofie J I Koomen, Anne Vrijmoet

|Nov 01, 2024
Spatial multiplex analysis of lung cancer reveals that regulatory T cells attenuate KRAS-G12C inhibitor-induced immune responses.

Megan Cole, Panayiotis Anastasiou, Claudia Lee

|Sep 30, 2024
Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in patients with resectable and borderline resectable lung cancer: the INCREASE study.

Idris Bahce, Chris Dickhoff, Famke L Schneiders

Pageof 2

Frequent Collaborators

6 joint publications

Julian Downward

4 joint publications

Katey S S Enfield

4 joint publications

Charles Swanton

4 joint publications

Emma Colliver